Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study

AIMS: Interleukin-22 (IL-22) has beneficial effects on body weight, insulin resistance and inflammation in different mouse models, but its relevance for the development of type 2 diabetes in humans is unknown. We aimed to identify correlates of serum IL-22 levels and to test the hypothesis that high...

Descripción completa

Detalles Bibliográficos
Autores principales: Herder, Christian, Kannenberg, Julia M., Carstensen-Kirberg, Maren, Huth, Cornelia, Meisinger, Christa, Koenig, Wolfgang, Peters, Annette, Rathmann, Wolfgang, Roden, Michael, Thorand, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282888/
https://www.ncbi.nlm.nih.gov/pubmed/28143481
http://dx.doi.org/10.1186/s12933-017-0498-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282888/
https://www.ncbi.nlm.nih.gov/pubmed/28143481
http://dx.doi.org/10.1186/s12933-017-0498-6

Ejemplares similares